Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.6 USD | +1.18% | +2.02% | +9.14% |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 14/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 18/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 31/10/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 01/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 07/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 31/10/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 25/04/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 12/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 10/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 06/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 14/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 30/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 19/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 19/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 10/08/22 |
Director/Board Member | 39 | 10/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 18/06/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,542 | 13,636,212 ( 61.15 %) | 0 | 61.15 % |
Company contact information
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.14% | 200M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OTLK Stock
- Company Outlook Therapeutics, Inc.